Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Cost implications of actual and potential adverse events prevented by interventions of a critical care pharmacist.

Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23):2483-7.

Save
Print
December 5, 2007
Kopp BJ, Mrsan M, Erstad BL, et al. Am J Health Syst Pharm. 2007;64(23):2483-7.
View more articles from the same authors.

Past studies have discussed the impact of clinical pharmacists on improving hospital care and preventing medication errors. This study discovered that chart review activities and participation in patient care rounds were associated with the greatest number of pharmacist interventions and potential cost savings.

Save
Print
Cite
Citation

Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23):2483-7.

Related Resources From the Same Author(s)
Related Resources